Tirzepatide Acetate – 15mg
$96.26
Tirzepatide Acetate is a 39-amino acid, dual GIP and GLP-1 receptor agonist engineered for research into metabolic disorders, insulin sensitivity, and energy balance regulation. This peptide is a synthetically modified analog incorporating a C20 fatty diacid for enhanced half-life and albumin binding, supporting long-acting incretin-based research applications.
Supplied as a lyophilized acetate salt, Tirzepatide Acetate is optimized for sterility, stability, and extended shelf life. Provided in a 3mL vial, this lipidated peptide is ideal for studies involving glucose homeostasis, appetite modulation, and body weight regulation.
Solubility: Tirzepatide Acetate is soluble in sterile water, dilute acetic acid, or aqueous buffers at pH 5–7.
For laboratory research use only. Not for human or veterinary applications.
Description
TTirzepatide Acetate
Chemical Name: Tirzepatide Acetate
Molecular Formula: C₂₂₅H₃₄₂N₄₆O₆₈
Molecular Weight: ~4813.5 g/mol
CAS Number: 2023788-19-2
Sequence:
H-His-Ala-Ala-Pro-Ser-Pro-Gly-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Gly-Glu-Gly-Val-Gly-Gly-Gly-Gly-Cys-Lys(AEEA-C20 diacid)-Ala-Ala-Ala-Glu-Gly-Glu-Leu-Gln-Gly-Ala-Leu-Glu-Gly-Gly-Gly-Thr-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly-Arg-Gly-Cys-His-Ala-Ile-Ala-Asp-Leu-Glu-Ser-Leu-Gln-Gly-Glu-Leu-Ser-Ser-Leu-Gln-Ser-Glu-Leu-Ser-Glu-Gly-Ala-Gln-Ala-Lys-NH₂
Structural Characteristics:
Tirzepatide is a 39-amino acid synthetic peptide analog that functions as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor. It is lipidated at Lys20 via a hydrophilic AEEA linker to a C20 fatty diacid, enhancing albumin binding and extending plasma half-life.
Mechanism of Action (Research Context):
Tirzepatide has been studied for its ability to activate both GIP and GLP-1 receptors, with research applications in:
- Glycemic regulation and insulin sensitivity models
- Appetite and satiety signaling studies
- Body weight and adiposity reduction research
- Lipid metabolism and metabolic syndrome investigations
Synthesis and Quality Control:
- Produced via solid-phase peptide synthesis (SPPS) with site-specific lipidation
- HPLC purified to ≥98%
- Identity confirmed by Mass Spectrometry (MS)
Product Details:
- Form: Lyophilized acetate salt
- Appearance: White to off-white powder
- Supplied in: 3mL sterile vial
Solubility & Reconstitution:
Soluble in sterile water, dilute acetic acid, or aqueous buffers at pH 5–7.
- Swirl gently to dissolve; avoid vigorous shaking
- Protect from high pH and oxidative conditions
Storage & Handling:
- Store lyophilized powder at –20°C, away from light and moisture
- After reconstitution, refrigerate at 2–8°C for up to 30 days
- For extended storage, aliquot and freeze at –20°C
- Avoid repeated freeze-thaw cycles
Disclaimer:
For research use only. Not for human or veterinary use. Not for diagnostic or therapeutic applications.
Additional information
| Weight | .06 lbs |
|---|---|
| Dimensions | .5 × .5 × 1 in |
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.